Brief: Enorama Resolves on Rights Issue, Gets Proceeds Of About SEK 28.65 Mln
Feb 23 (Reuters) - Enorama Pharma AB (publ) ERMA.ST :
* SAID ON THURSDAY DECIDED ON RIGHTS ISSUE
* TO RECEIVE ISSUE PROCEEDS OF ABOUT SEK 28.65 MILLION
BEFORE
DEDUCTION OF ISSUE COSTS
Source text for Eikon: urn:newsml:reuters.com:*:nWkr34FMlX
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO